Patient-Derived Xenografts to Reduce Cancer Health Disparities (NCT04410302)
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
🩺 Plain-English Summary (8th-Grade Level)
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Who can join: Review the eligibility criteria below.
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
Age range: 21 Years to 100 Years
🧪 Interventions in This Study
- Biospecimen Collection (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
- University of California Davis Comprehensive Cancer Center — Sacramento, California
📞 Contact the Study Coordinator
Phone: (916) 734-1587
Email: tfle@ucdavis.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Bladder Carcinoma
- Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery — Duarte, California
- Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers — Los Angeles, California
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers — Duarte, California
- Bladder Bank (a Prospective Banking Study) — Rochester, Minnesota
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Birmingham, Alabama
- The Vanguard Study: Testing a New Way to Screen for Cancer — Pleasanton, California
Explore by condition: All Bladder Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.